CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Bronchoscopy with bilateral bronchoalveolar lavagesprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03034642
NCT03034642N/ACompleted
CompareCT.gov

Modulation of Steroid Immunosuppression by Alveolar Efferocytosis

VA Ann Arbor Healthcare System·interventional·Posted Jan 27, 2017·Updated May 3, 2022

In Brief

A clinical study evaluating Bronchoscopy with bilateral bronchoalveolar lavages for Pulmonary Disease, Chronic Obstructive and Pneumonia, Bacterial. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The long-term goals of this study are (a) to understand the biological underpinnings for the increased incidence of community-acquired pneumonia in patients with chronic obstructive pulmonary disease (COPD) who are treated with inhaled corticosteroids; and (b) to develop novel therapies to treated this problem using over-expression of micro-RNAs (miRNAs).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive, Pneumonia, Bacterial
CountriesUnited States
CollaboratorsUniversity of Michigan

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 27, 2017
Enrollment StartOct 1, 2015
Primary CompletionMar 20, 2020
Study CompletionDec 30, 2021
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 9.4 years ago

Interventions

Bronchoscopy with bilateral bronchoalveolar lavagesprocedure

Bronchoscopy with bilateral bronchoalveolar lavages